Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points

Carcinogenesis

Volumn 22, Issue 7, 2001, Pages 999-1013

  De Flora, S ^a   Izzotti, A ^a   D'Agostini, F ^a   Balansky, R M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ASCORBIC ACID; CARCINOGEN; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; CYSTEINE; CYTOTOXIC AGENT; DOXORUBICIN; GLUTATHIONE; ISOTHIOCYANIC ACID;

ALOPECIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER CONTROL; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL CYCLE; CELL NUCLEUS; CELL SURVIVAL; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DNA DAMAGE; DNA MICROARRAY; DNA REPAIR; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EXPERIMENTAL ANIMAL; GENE EXPRESSION; GENE MUTATION; GENOTOXICITY; HEART DISEASE; HIGH RISK PATIENT; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNITY; IN VITRO STUDY; INHIBITION KINETICS; LONG TERM CARE; LUNG CANCER; LUNG PARENCHYMA; MALIGNANT TRANSFORMATION; METABOLISM; METASTASIS; MITOCHONDRION; MODULATION; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTECTION; PROTEIN DEPLETION; RAT; REVIEW; SIGNAL TRANSDUCTION; SMOKING; SMOKING CESSATION; URINARY TRACT DISEASE;

EID: 0034929864     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.7.999     Document Type: Review

References (196)

1. Prevention of cancer in the next millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research
2. Multiple points of intervention in the prevention of cancer and other mutation related diseases
3. Metabolism and function of glutathione
4. Mechanisms of anticarcinogenesis: The example of N-acetylcysteine
5. The effect of oral N-acetylcysteine in chronic bronchitis: A quantitative systematic review
6. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment
7. Oxidative stress in chronic obstructive pulmonary disease
8. In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens
9. Role of glutathione and N-acetylcysteine as inhibitors of mutagenesis and carcinogenesis
10. Antimutagenic and anticarcinogenic mechanisms of aminothiols
11. Antioxidant activity and other mechanisms of thiols in chemoprevention of mutation and cancer
12. Chemopreventive properties of N-acetylcysteine and other thiols
13. N-Acetyl-L-cysteine
14. Clinical development plans for cancer chemopreventive agents: N-acetylcysteine
15. Chemopreventive properties and mechanisms of N-acetylcysteine. The experimental background
16. Tobacco smoking
17. Cigarette smoke and the involvement of free radical reactions in chemical carcinogenesis
18. Oxidants, oxidative stress and the biology of ageing
19. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview
20. Mechanisms of inhibitors of genotoxicity. Relevance in preventive medicine
21. Mechanisms of food-borne inhibitors of genotoxicity relevant to cancer prevention
22. Classification and mechanisms of action of chemopreventive compounds
23. Mechanisms of antimutagenesis and anticarcinogenesis. Role in primary prevention
24. Mechanisms of inhibitors of mutagenesis and carcinogenesis
25. Rationale and mechanisms of cancer chemoprevention
26. Antigenotoxic and anticarcinogenic effects of thiols. In vitro inhibition of the mutagenicity of drug nitrosation products and protection of rat liver ADP-ribosyl transferase activity
27. The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-κB
28. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells
29. Benzo(a) pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-κB
30. N-Acetylcysteine attenuates acute lung injury in the rat
31. Role of reactive of oxygen intermediates in the decrease of hepatic cytochrome P450 activity by serum of humans and rabbits with an acute inflammatory reaction
32. Glutathione metabolism and utilization of external thiols by cigarette smoke-challenged, isolated rat and rabbit lungs
33. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds
34. Dual role of thiols in N-methyl-N-nitro-N-nitrosoguanidine genotoxicity
35. Smokers and urinary genotoxins. Implications for selection of cohorts and modulation of endpoints in chemoprevention trials
36. N-Acetylcysteine protects against age-related decline of oxidative phosphorylation in liver mitochondria
37. An in vitro model of ischemic-like stress in retinal pigmented epithelium cells: Protective effects of antioxidants
38. Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs
39. Tobacco smoke induces mitochondrial depolarization along with cell death: Effects of antioxidants
40. N-Acetylcysteine protects against age-related increase in oxidized proteins in mouse synaptic mitochondria
41. Prevention by N-acetylcysteine of benzo[a]pyrene clastogenicity and DNA adducts in rats
42. Chemoprevention of smoke-related DNA adduct formation in rat lung and heart
43. Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases
44. Inhibition by N-acetylcysteine of carcinogen-DNA adducts in the tracheal epithelium of rats exposed to cigarette smoke
45. Biomarker alterations produced in rat lung by intratracheal instillation of air particulate extracts, and chemoprevention with oral N-acetylcysteine
46. 32P postlabeled modifications and formation of 8-hydroxy-2′-deoxyguanosine in the lung but not in the liver of rats receiving intratracheal instillations of by N-acetylcysteine
47. Modulation of biomarkers by chemopreventive agents in smoke-exposed rats
48. N-Acetylcysteine treatment lowers 4-aminobiphenyl haemoglobin adduct levels in non-smokers
49. Inhibition of the 'spontaneous' mutagenicity in Salmonella typhimurium TA102 and TA104
50. Methyl-donors deficiency due to chemically induced glutathione depletion
51. Protection of molecular enzymes by aminothiols
52. Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents
53. Antioxidant action via p53-mediated apoptosis
54. p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E
55. Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells
56. Suppression of nerve growth factor-induced neuronal differentiation of PC12 cells
57. Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression
58. Supplementation of N-acetylcysteine inhibits NFκB activation and protects against alloxan-induced diabetes in CD-1 mice
59. N-Acetylcysteine suppresses TNF-induced NF-κB activation through inhibition of IκB kinases
60. Biphasic effects of UVA radiation on STAT1 activity and tyrosine phosphorylation in cultured human keratinocytes
61. The pathway regulating GADD153 induction in response to DNA damage is independent of protein kinase C and tyrosine kinases
62. Thiol antioxidant, N-acetylcysteine, activates extracellular signal-regulated kinase signaling pathway in articular chondrocytes
63. 1 prolongation by the chemopreventive agent N-acetylcysteine
64. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-α-induced cell death
65. Reduction of endothelial cell related TGF-β activity by thiols
66. 2
67. Activation of c-Ha-ras by benzo[a]pyrene in vascular smooth muscle cells involves redox stress and aryl hydrocarbon receptor
68. Alopecia and hair follicle cell apoptosis in mice exposed to environmental cigarette smoke
69. Nutritional antioxidants and the modulation of inflammation: Theory and practice
70. N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production
71. N-Acetylcysteine inhibits IL-1α-induced IL-8 secretion by bronchial epithelial cells
72. Induction, persistence and modulation of cytogenetic alterations in cells of smoke-exposed mice
73. Tumor promotion by hydrogen peroxide in rat liver epithelial cells
74. The anti-inflammatory activity of Ebselen but not thiols in experimental alveolitis and bronchiolitis
75. Inhibition by oral N-acetylcysteine of cigarette smoke-induced 'bronchitis' in the rat
76. Oral N-acetylcysteine or S-carboxymethylcysteine inhibit cigarette smoke-induced hypersecretion of mucus in rat larynx and trachea in situ
77. Protection by N-acetylcysteine of the histopathological and cytogenetical damage produced by exposure of rats to cigarette smoke
78. N-Acetylcysteine prevents cigarette smoke induced small airways alterations in rats
79. 2 in rat heart endothelial cells
80. Vascular endothelial growth factor (VEGF) and melanoma. N-Acetylcysteine downregulates VEGF production in vitro
81. N-Acetylcysteine inhibits endothelial cell invasion and angiogenesis while protecting from apoptosis
82. The suppression of T cell function and NFκB expression by serine protease inhibitors is blocked by N-acetylcysteine
83. Improvement of immune functions in HIV infection by sulfur supplementation: Two randomized trials
84. Effective elimination of lung metastases induced by tumor cells treated with hydrostatic pressure and N-acetyl-L-cysteine
85. Effects in vitro of several antioxidants on the natural killer function of aging mice
86. Chemopreventive potential of fumaric acid, N-acetylcysteine, N-(4-hydroxyphenyl) retinamide and β-carotene for tobacco-nitrosamine-induced lung tumors in A/J mice
87. 1 pathways
88. Proliferation of cultured human astrocytoma cells in response to an oxidant and antioxidant
89. Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress
90. N-Acetylcysteine suppression of the proliferative index in the colon of patients with previous adenomatous colonic polyps
91. Topical N-acetylcysteine for lamellar ichthyosis
92. N-Acetylcysteine enhances cell adhesion properties of epithelial and lymphoid cells
93. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine
94. Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models
95. N-Acetyl-L-cysteine exhibits antitumoral activity by increasing tumor necrosis factor α-dependent T-cell cytotoxicity
96. Oral N-acetylcysteine inhibition of doxorubicin-induced clastogenicity and alopecia: Interaction between the two drugs in preventing primary tumors and lung micrometastases in mice
97. Cellular thiols status and cell death in the effect of green tea polyphenols in Ehrlich ascites tumor cells
98. Interactions between N-acetylcysteine and ascorbic acid in modulating mutagenesis and carcinogenesis
99. Chemopreventive activity of thiol conjugates of isothiocyanates for lung tumorigenesis
100. Protection by N-acetylcysteine of cyclophosphamide metabolism related in vivo depression of mixed function oxygenase activity and in vitro denaturation of cytochrome P-450
101. Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine
102. 2-Acetyl-aminofluorence up-regulates rat mdrlb expression through generating reactive oxygen species that activate NF-κB pathway
103. Reactive oxygen species participate in mdrlb mRNA and P-glycolprotein overexpression in primary rat hepatocytes cultures
104. N-Acetylcysteine slows down ageing and increases the life span of Drosophila melanogaster
105. The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and rewires NF-κB (RelA)-sensitive targeting
106. Activity profiles of antimutagens. In vitro and in vivo data
107. Synergistic induction of DNA strand breakage by cigarette tar and nitric oxide
108. 2P postlabeling
109. Evaluation of antioxidant potential of natural and synthetic agents in vitro
110. Differential effects of thiols on DNA modifications via alkylation and Michael addition by α-acetoxy-N-nitrosopyrrolidine
111. Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents
112. Effect of cancer chemopreventive agents on microsome-mediated DNA adduction of the breast carcinogen dibenzo [a,l] pyrene
113. Inhibition of mutagenesis and carcinogenesis by N-acetylcysteine
114. Vinyl carbamate epoxide, a major strong elecrophilic, mutagenic and carcinogenic metabolite of vinyl carbamate and ethyl carbamate (urethane)
115. Detoxification of genotoxic compounds as a threshold mechanism limiting their carcinogenicity
116. Effects of oxygen radical scavengers and antioxidants on phagocyte induced mutagenesis
117. Mutagenicity of active oxygen species in bacteria and its enzymatic or chemical inhibition
118. Genotoxicity of volatile and secondary reactive oxygen species generated by photosensitization
119. Desmutagenic effects of N-acetylcysteine on direct and indirect mutagens
120. The effect of N-acetylcysteine on the toxicity induced by N-nitroso-dimethylamine
121. Experimental databases on inhibition of the bacterial mutagenicity of 4-nitroquinoline 1-oxide and cigarette smoke
122. Cigarette smoke induces DNA damage in the human B-lymphoid cell line Raji
123. Effects of antioxidants on oxidant-induced sister chromatid exchange formation
124. Antiapoptotic and antigenotoxic effects of N-acetylcysteine in human cell of endothelial origin
125. The cellular stress response induced by aqueous extracts of cigarette smoke is critically dependent on the intracellular glutathione concentration
126. Heme oxygenase expression in Swiss 3T3 cells following exposure to aqueous cigarette lsmoke fractions
127. Effects of thiols on topoisomerase-II α activity and cell cycle progression
128. N-Acetylcysteine protection against the toxicity of cigarette smoke and cigarette smoke condensates in various tissues and cells in vitro
129. Lung protection by a thiol-containing antioxidant: N-acetylcysteine
130. Acute effects of tobacco smoke on alveolar macrophages cultured in gas phase
131. Prevention of in vitro oxidant-mediated alveolar macrophage injury by cellular glutathione and precursors
132. Induction of stress proteins by tobacco smoke in human monocytes: Modulation by antixodants
133. Inhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51
134. Induction of heme oxygenase-1 expression in macrophages by diesel exhaust particle chimicals and quinones via the antioxidant-responsive element
135. N-Acetylcysteine and glutathione-dependent protective effect of PZ51 (Ebselen) against diquat-induced cytotoxicity in isolated hepatocytes
136. Heterologous expression of rat P450 2E1 in a mammalian cell line: In situ metabolism and cytotoxicity of N-nitrosodimethylamine
137. Detection of 2-amino-3-methylimidazo1[4,5-f]quinoline in cigarette smoke condensate
138. Protective effect of N-acetylcysteine against heterocyclic amine-induced cardiotoxicity in cultured myocytes and in rats
139. Induction of endothelial cell injury by cigarette smoke
140. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract - Role of free radicals and attenuation by captopril
141. Glutathione redox cycle is an important defense system of endothelial cells against chronic hyperoxia
142. Comparative study on the selenium- and N-acetylcysteine-related effects on the toxic action of hyperoxia, paraquat and the enzyme reaction hypoxanthine-xanthine oxidase in cultured endothelial cells
143. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells
144. Metabolic alterations produced by cigarette smoke in rat lung and liver, and their modulation by oral N-acetylcysteine
145. Detoxifying activities in alveolar macrophages of rats treated with acetylcysteine, diethyl maleate and/or Aroclor
146. Inhibition of urethan-induced lung tumors in mice by dietary N-acetylcysteine
147. Tumor induction in tracheal grafts. A new experimental model for respiratory carcinogenesis studies
148. Inhaled cigarette smoke induces preneoplastic changes in rat tracheal epithelial cells
149. Effects of dietary supplementation of N-acetylcysteine on cigarette smoke-related DNA adducts in rat tissues
150. Carcinogenicity study with sodium dichromate in rats
151. Less than additive interaction between cigarette smoke and chromium (VI) in inducing clastogenic damage in rodents
152. Mitochondrial genetics: A paradigm for aging and degenerative diseases
153. Impaired alveolar macrophages chemotaxis in patients with acute smoke inhalation
154. Alterations in macropahge functions by environmental chemicals
155. N-Acetylcysteine enhances in vitro the intracellular killing of Staphylococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing
156. Failure of N-acetylcysteine to protect the mouse bone marrow against the clastogenicity of 7,12 dimethylbenzanthracene
157. Chemoprevention by N-acetylcysteine of urethane-induced lung tumors in mice, as related to the time-course monitoring of micronuclei in peripheral blood erythrocytes
158. Modulation of apoptosis by cigarette smoke and cancer chemopreventive agents in the respiratory tract of rats
159. Alveolar macrophage apoptosis and TNF-α, but not p53, expression correlate with murine response to bleomycin
160. The involvement of Fas-Fas ligand pathway in fibrosis lung diseases
161. The potential role of BAX and BCL-2 expression in diffuse alveolar damage
162. Axotomy-induced retinal ganglion cell death in development: Its time-course and its diminution by antioxidants
163. Beneficial effects of antioxidants in diabetes: Possible protection of pancreatic β-cells against glucose toxicity
164. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype
165. Protective actin of sulfur compounds against aldehyde toxicants of cigarette smoke
166. Effect of oral N-acetylcysteine (NAC) on volume and albumin content of respiratory tract fluid but not on epithelial secretory cell number in 'smoking' rats
167. A review of the chronic inhalation studies with mainstream cigarette smoke in rats and mice
168. The carcinogencity of environmental tobacco smoke
169. The carcinogenic potential of the gas phase of environmental tobacco smoke
170. Pilot studies evaluating the lung tumor yield in cigarette smoke-exposed mice
171. The effects of phenethyl isothiocyanate, N-acetylcysteine and green tea on tobacco smoke-induced lung tumors in strain A/J mice
172. Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myoinositol and dexamethasone
173. Chemoprevention of tobacco smoke lung carcinogenesis in mice after cessation of smoke exposure
174. Chemopreventive efficacy of arylalkylisothiocyanates and N-acetylcysteine for lung tumorigenesis in Fischer rats
175. Identification and quantification of the N-acetylcysteine conjugate of allyl isothiocyanate in human urine after ingestion of mustard
176. N-Acetylcysteine conjugates of isothiocyanates inhibit lung tumors induced by a tobacco carcinogen at post-initiation stages
177. Pathobiological effects of aldehydes in cultured human bronchial cells
178. Screening for chemopreventive (anticarcinogenic) compounds in rodents
179. Haemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers
180. Colorectal adenomatous and hyperplastic polyps: Smoking and N-acetyltransferase 2 polymorphisms
181. Increased risk of colorectal cancer among smokers: Results of a 26-year follow-up of US veterans and a review
182. Genetic and cellular changes in colorectal cancer: Proposed targets of chemopreventive agents
183. Chemoprevention of colorectal tumors: Role of lactulose and of other agents
184. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer
185. Cancer, cigarette smoking and premature death in Europe: A review including the Recommendations of the European Cancer Experts Consensus Meeting, Helsinki, October 1996
186. DNA adducts in chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine
187. Molecular epidemiology of atherosclerosis
188. Epidemiology of lung cancer
189. Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention
190. Pharmacokinetic and pharmaco- dynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial
191. Dose dependent pharmacokinetics of N-acetylcysteine after oral dosing to man
192. Experience with acetylcysteine in cystinuric patients
193. Intravenous N-acetylcysteine: The treatment of choice for paracetamol poisoning
194. The toxicity of N-acetylcysteine in laboratory animals